With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.33537-99-4,6-Chloro-1,2,3,4-tetrahydroisoquinoline,as a common compound, the synthetic route is as follows.
33537-99-4, To a solution of 6-chloro-1 ,2,3,4-tetrahydroisoquinoline (18.5 g, 0.1 1 mol) in CH3CN (180 mL) was added compound 2,3-dimethyl-1 -((2-methyl-1 H-imidazol-1 -yl)sulfonyl)- 1 H-imidazol-3-ium trifluoromethanesulfonate (43.5 g, 0.1 1 mol, Reference: J. Org. Chem. 2002, 68, 1 15-1 19.). The reaction mixture was stirred overnight at 30 C. The solvent was removed and the residue was purified by column chromatography on silica gel (0400) (EtOAc/Petroleum ether = 1 :1 ) to provide 6-chloro-2-(2-methyl-1 /-/-imidazol-1 -ylsulfonyl)- 1 ,2,3,4-tetrahydroisoquinoline. 1 H NMR (400 MHz, CDCI3): d 7.21 (m, 1 H), 7.18 (s, 1 H), 7.02 (m, 1 H), 6.94 (m, 1 H), 4.45 (s, 2H), 3.62 (m, 2H), 2.92 (m, 2H), 2.67 (s, 3H).
As the paragraph descriping shows that 33537-99-4 is playing an increasingly important role.
Reference£º
Patent; KEZAR LIFE SCIENCES; JOHNSON, Henry; (166 pag.)WO2019/178510; (2019); A1;,
Tetrahydroisoquinoline – Wikipedia
1,2,3,4-Tetrahydroisoquinoline | C9H11N – PubChem